Cleared Traditional

K932442 - CARDIO REP RECOMBINANT CK ABNORMAL CONTROL

K932442 is an FDA 510(k) clearance for CARDIO REP RECOMBINANT CK ABNORMAL CONTROL, manufactured by Helena Laboratories. The device is a Class 1 Chemistry device with product code JJT cleared through the Traditional 510(k) pathway after a 161-day FDA review.

K932442 · Helena Laboratories · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1993
Decision
161d
Days
Class 1
Risk

K932442 is an FDA 510(k) clearance for the CARDIO REP RECOMBINANT CK ABNORMAL CONTROL. Classified as Enzyme Controls (assayed And Unassayed) (product code JJT), Class I - General Controls.

Submitted by Helena Laboratories (Beaumont, US). The FDA issued a Cleared decision on October 28, 1993 after a review of 161 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Helena Laboratories devices

FDA 510(k) Submission Details - K932442

510(k) Number K932442 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 20, 1993
Decision Date October 28, 1993
Days to Decision 161 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
73d slower than avg
Panel avg: 88d · This submission: 161d
Pathway characteristics
Predicate-based equivalence.

JJT Device Classification - Class 1, General Controls

Product Code JJT Enzyme Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJT Enzyme Controls (assayed And Unassayed)

All 80
Devices cleared under the same product code (JJT) and FDA review panel - the closest regulatory comparables to K932442.
CARDIOSPEX(TM) LIQUID CKMB/LD-1 IMMUNOINHIBITION
K946146 · Clinical Controls, Inc. · Jan 1995
CKMB/MYOGLOBIN MASS MEASUREMENY CONTROL LEVEL 1, 2, 3,
K944923 · Clinical Controls, Inc. · Nov 1994
HICHEM ENZYME VERIFIER KIT
K943684 · Hi Chem, Inc. · Oct 1994
ROCHE CARDIOTROL-CK
K930889 · Roche Diagnostic Systems, Inc. · Jul 1993
LIQUICHEK CK-MB CONTROL LEVELS 1,2, AND3
K925151 · Bio-Rad · Dec 1992
CK-MB IMMUNOASSAY CONTROL
K905623 · Seradyn, Inc. · Feb 1991